Innovotech Inc. Receives Support to Develop Antimicrobial Testing Services and Product Enhancements

Edmonton, Alberta – May 13, 2026 - TheNewswire – Innovotech Inc. (TSX Venture Exchange: IOT ; OTCQB: IOTCF ) (“Innovotech” or the “Company”) reports that its subsidiary Innovotech Labs Corporation is receiving advisory services and research and development funding of up to $234,000 CAD from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the development of new antimicrobial testing services for use with medical devices such as catheters, implants, and wound dressings.   The new testing methods align with changes in international regulatory standards and medical device manufacturers' needs in the areas of proliferation, biofilm formation, and translocation of microorganisms. This work builds on foundational development started last year and advances it into more robust, fit-for-purpose testing. As customer programs expand, manufacturers are requesting more advanced testing that better reflects real-world use and provides clearer decision-making data. Strengthening these capabilities will expand the Company service offerings, support regulatory readiness, and help customers demonstrate device safety and performance more effectively.